Goldman Sachs has initiated coverage of Vera Therapeutics (NASDAQ:VERA) with a buy rating, citing the potential of its drug candidate atacicept and a recent pullback in the stock. The investment ...

Goldman Sachs analyst Paul Choi initiated coverage of Vera Therapeutics (VERA) with a Buy rating and $58 price target Following the recent ...

The Goldman Sachs Group started coverage on shares of Vera Therapeutics (NASDAQ:VERA – Free Report) in a research note issued to investors on Tuesday morning, Marketbeat reports. The firm issued ...

Goldman Sachs CEO David Solomon said that there's "some possibility" the company's Apple Card partnership with Apple could end early, reports Reuters. Goldman Sachs and Apple have a contract that ...

The revolving door between Goldman Sachs and the US government may be slowing after decades of executives jumping between the bank and the federal government, sources told NYNext. “We are no ...

Goldman Sachs has promoted several new executives for its major business lines, reflecting a shift in leadership, including two Indian Americans Anshul Sehgal and Kunal Shah.(Image: Pexels ...

Goldman Sachs and Houlihan Lokey have emerged as the leading financial advisers in the technology, media, and telecom (TMT) sector for mergers and acquisitions (M&A) in 2024, according to the ...

Goldman Sachs CEO David Solomon promoted a slew of top bankers on Tuesday to run the firm’s biggest business units, just days after the bank boss was awarded a pair of massive bonuses.

American Express National Bank and Marcus by Goldman Sachs are both popular online banks, each with a competitive high-yield savings account (HYSA) option. But in an environment where interest ...

Goldman Sachs on Tuesday announced a series of leadership appointments, expanding the size of its management committee and elevating several executives to its top ranks. The management committee ...

Apple and Goldman Sachs have had a fraught Apple Card relationship, which has widely been reported to be ending soon. Now, Goldman’s CEO has confirmed the possibility of a premature conclusion ...